Bioengineered Protein Drugs market worldwide is projected to grow by US$122 Billion, driven by a compounded growth of 7. 1%. Monoclonal Antibodies, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.

New York, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Bioengineered Protein Drugs Industry" - https://www.reportlinker.com/p05818034/?utm_source=GNW
5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$134.1 Billion by the year 2025, Monoclonal Antibodies will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$4.3 Billion to the region’s size and clout in the next 5 to 6 years. Over US$3.7 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Monoclonal Antibodies will reach a market size of US$6.8 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 10.5% over the next couple of years and add approximately US$33.8 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Abbott India Ltd.; Amgen, Inc.; Bayer AG; Biocon Ltd.; Dr. Reddy’s Laboratories Ltd.; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Johnson & Johnson; Merck & Co., Inc.; Novartis International AG; Panacea Biotec Ltd.; ProBioGen AG


Read the full report: https://www.reportlinker.com/p05818034/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Bioengineered Protein Drugs Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Bioengineered Protein Drugs Global Market Estimates
and Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Bioengineered Protein Drugs Global Retrospective
Market Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Bioengineered Protein Drugs Market Share Shift across
Key Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Monoclonal Antibodies (Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Monoclonal Antibodies (Type) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 6: Monoclonal Antibodies (Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Therapeutic Proteins (Type) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Therapeutic Proteins (Type) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 9: Therapeutic Proteins (Type) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Vaccines (Type) Geographic Market Spread Worldwide in
US$ Million: 2018 to 2025
Table 11: Vaccines (Type) Region Wise Breakdown of Global
Historic Demand in US$ Million: 2009 to 2017
Table 12: Vaccines (Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 13: Pharma & Biotech Companies (End-Use) Demand Potential
Worldwide in US$ Million by Region/Country: 2018-2025
Table 14: Pharma & Biotech Companies (End-Use) Historic Sales
Analysis in US$ Million by Region/Country: 2009-2017
Table 15: Pharma & Biotech Companies (End-Use) Share Breakdown
Review by Region/Country: 2009 VS 2019 VS 2025
Table 16: CROs (End-Use) Worldwide Latent Demand Forecasts in
US$ Million by Region/Country: 2018-2025
Table 17: CROs (End-Use) Global Historic Analysis in US$
Million by Region/Country: 2009-2017
Table 18: CROs (End-Use) Distribution of Global Sales by
Region/Country: 2009 VS 2019 VS 2025
Table 19: Academics (End-Use) Sales Estimates and Forecasts in
US$ Million by Region/Country for the Years 2018 through 2025
Table 20: Academics (End-Use) Analysis of Historic Sales in US$
Million by Region/Country for the Years 2009 to 2017
Table 21: Academics (End-Use) Global Market Share Distribution
by Region/Country for 2009, 2019, and 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Bioengineered Protein Drugs Market Share (in %) by Company:
2019 & 2025
Table 22: United States Bioengineered Protein Drugs Market
Estimates and Projections in US$ Million by Type: 2018 to 2025
Table 23: Bioengineered Protein Drugs Market in the United
States by Type: A Historic Review in US$ Million for 2009-2017
Table 24: United States Bioengineered Protein Drugs Market
Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 25: United States Bioengineered Protein Drugs Latent
Demand Forecasts in US$ Million by End-Use: 2018 to 2025
Table 26: Bioengineered Protein Drugs Historic Demand Patterns
in the United States by End-Use in US$ Million for 2009-2017
Table 27: Bioengineered Protein Drugs Market Share Breakdown in
the United States by End-Use: 2009 VS 2019 VS 2025
CANADA
Table 28: Canadian Bioengineered Protein Drugs Market Estimates
and Forecasts in US$ Million by Type: 2018 to 2025
Table 29: Canadian Bioengineered Protein Drugs Historic Market
Review by Type in US$ Million: 2009-2017
Table 30: Bioengineered Protein Drugs Market in Canada:
Percentage Share Breakdown of Sales by Type for 2009, 2019, and
2025
Table 31: Canadian Bioengineered Protein Drugs Market
Quantitative Demand Analysis in US$ Million by End-Use: 2018 to
2025
Table 32: Bioengineered Protein Drugs Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 33: Canadian Bioengineered Protein Drugs Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
JAPAN
Table 34: Japanese Market for Bioengineered Protein Drugs:
Annual Sales Estimates and Projections in US$ Million by Type
for the Period 2018-2025
Table 35: Bioengineered Protein Drugs Market in Japan: Historic
Sales Analysis in US$ Million by Type for the Period 2009-2017
Table 36: Japanese Bioengineered Protein Drugs Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 37: Japanese Demand Estimates and Forecasts for
Bioengineered Protein Drugs in US$ Million by End-Use: 2018 to
2025
Table 38: Japanese Bioengineered Protein Drugs Market in US$
Million by End-Use: 2009-2017
Table 39: Bioengineered Protein Drugs Market Share Shift in
Japan by End-Use: 2009 VS 2019 VS 2025
CHINA
Table 40: Chinese Bioengineered Protein Drugs Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 41: Bioengineered Protein Drugs Historic Market Analysis
in China in US$ Million by Type: 2009-2017
Table 42: Chinese Bioengineered Protein Drugs Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 43: Chinese Demand for Bioengineered Protein Drugs in US$
Million by End-Use: 2018 to 2025
Table 44: Bioengineered Protein Drugs Market Review in China in
US$ Million by End-Use: 2009-2017
Table 45: Chinese Bioengineered Protein Drugs Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Bioengineered Protein Drugs Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 46: European Bioengineered Protein Drugs Market Demand
Scenario in US$ Million by Region/Country: 2018-2025
Table 47: Bioengineered Protein Drugs Market in Europe: A
Historic Market Perspective in US$ Million by Region/Country
for the Period 2009-2017
Table 48: European Bioengineered Protein Drugs Market Share
Shift by Region/Country: 2009 VS 2019 VS 2025
Table 49: European Bioengineered Protein Drugs Market Estimates
and Forecasts in US$ Million by Type: 2018-2025
Table 50: Bioengineered Protein Drugs Market in Europe in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 51: European Bioengineered Protein Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 52: European Bioengineered Protein Drugs Addressable
Market Opportunity in US$ Million by End-Use: 2018-2025
Table 53: Bioengineered Protein Drugs Market in Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 54: European Bioengineered Protein Drugs Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
FRANCE
Table 55: Bioengineered Protein Drugs Market in France by Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 56: French Bioengineered Protein Drugs Historic Market
Scenario in US$ Million by Type: 2009-2017
Table 57: French Bioengineered Protein Drugs Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 58: Bioengineered Protein Drugs Quantitative Demand
Analysis in France in US$ Million by End-Use: 2018-2025
Table 59: French Bioengineered Protein Drugs Historic Market
Review in US$ Million by End-Use: 2009-2017
Table 60: French Bioengineered Protein Drugs Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
GERMANY
Table 61: Bioengineered Protein Drugs Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 62: German Bioengineered Protein Drugs Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 63: German Bioengineered Protein Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 64: Bioengineered Protein Drugs Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2018-2025
Table 65: German Bioengineered Protein Drugs Market in
Retrospect in US$ Million by End-Use: 2009-2017
Table 66: Bioengineered Protein Drugs Market Share Distribution
in Germany by End-Use: 2009 VS 2019 VS 2025
ITALY
Table 67: Italian Bioengineered Protein Drugs Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 68: Bioengineered Protein Drugs Historic Market Analysis
in Italy in US$ Million by Type: 2009-2017
Table 69: Italian Bioengineered Protein Drugs Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 70: Italian Demand for Bioengineered Protein Drugs in US$
Million by End-Use: 2018 to 2025
Table 71: Bioengineered Protein Drugs Market Review in Italy in
US$ Million by End-Use: 2009-2017
Table 72: Italian Bioengineered Protein Drugs Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
UNITED KINGDOM
Table 73: United Kingdom Market for Bioengineered Protein
Drugs: Annual Sales Estimates and Projections in US$ Million by
Type for the Period 2018-2025
Table 74: Bioengineered Protein Drugs Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Type for the
Period 2009-2017
Table 75: United Kingdom Bioengineered Protein Drugs Market
Share Analysis by Type: 2009 VS 2019 VS 2025
Table 76: United Kingdom Demand Estimates and Forecasts for
Bioengineered Protein Drugs in US$ Million by End-Use: 2018 to
2025
Table 77: United Kingdom Bioengineered Protein Drugs Market in
US$ Million by End-Use: 2009-2017
Table 78: Bioengineered Protein Drugs Market Share Shift in the
United Kingdom by End-Use: 2009 VS 2019 VS 2025
SPAIN
Table 79: Spanish Bioengineered Protein Drugs Market Estimates
and Forecasts in US$ Million by Type: 2018 to 2025
Table 80: Spanish Bioengineered Protein Drugs Historic Market
Review by Type in US$ Million: 2009-2017
Table 81: Bioengineered Protein Drugs Market in Spain:
Percentage Share Breakdown of Sales by Type for 2009, 2019, and
2025
Table 82: Spanish Bioengineered Protein Drugs Market
Quantitative Demand Analysis in US$ Million by End-Use: 2018 to
2025
Table 83: Bioengineered Protein Drugs Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 84: Spanish Bioengineered Protein Drugs Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
RUSSIA
Table 85: Russian Bioengineered Protein Drugs Market Estimates
and Projections in US$ Million by Type: 2018 to 2025
Table 86: Bioengineered Protein Drugs Market in Russia by Type:
A Historic Review in US$ Million for 2009-2017
Table 87: Russian Bioengineered Protein Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 88: Russian Bioengineered Protein Drugs Latent Demand
Forecasts in US$ Million by End-Use: 2018 to 2025
Table 89: Bioengineered Protein Drugs Historic Demand Patterns
in Russia by End-Use in US$ Million for 2009-2017
Table 90: Bioengineered Protein Drugs Market Share Breakdown in
Russia by End-Use: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 91: Rest of Europe Bioengineered Protein Drugs Market
Estimates and Forecasts in US$ Million by Type: 2018-2025
Table 92: Bioengineered Protein Drugs Market in Rest of Europe
in US$ Million by Type: A Historic Review for the Period
2009-2017
Table 93: Rest of Europe Bioengineered Protein Drugs Market
Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 94: Rest of Europe Bioengineered Protein Drugs
Addressable Market Opportunity in US$ Million by End-Use:
2018-2025
Table 95: Bioengineered Protein Drugs Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 96: Rest of Europe Bioengineered Protein Drugs Market
Share Analysis by End-Use: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 97: Asia-Pacific Bioengineered Protein Drugs Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 98: Bioengineered Protein Drugs Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 99: Asia-Pacific Bioengineered Protein Drugs Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 100: Bioengineered Protein Drugs Market in Asia-Pacific
by Type: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 101: Asia-Pacific Bioengineered Protein Drugs Historic
Market Scenario in US$ Million by Type: 2009-2017
Table 102: Asia-Pacific Bioengineered Protein Drugs Market
Share Analysis by Type: 2009 VS 2019 VS 2025
Table 103: Bioengineered Protein Drugs Quantitative Demand
Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
Table 104: Asia-Pacific Bioengineered Protein Drugs Historic
Market Review in US$ Million by End-Use: 2009-2017
Table 105: Asia-Pacific Bioengineered Protein Drugs Market
Share Analysis: A 17-Year Perspective by End-Use for 2009,
2019, and 2025
AUSTRALIA
Table 106: Bioengineered Protein Drugs Market in Australia:
Recent Past, Current and Future Analysis in US$ Million by Type
for the Period 2018-2025
Table 107: Australian Bioengineered Protein Drugs Historic
Market Analysis in US$ Million by Type: 2009-2017
Table 108: Australian Bioengineered Protein Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 109: Bioengineered Protein Drugs Market in Australia:
Annual Sales Estimates and Forecasts in US$ Million by End-Use
for the Period 2018-2025
Table 110: Australian Bioengineered Protein Drugs Market in
Retrospect in US$ Million by End-Use: 2009-2017
Table 111: Bioengineered Protein Drugs Market Share
Distribution in Australia by End-Use: 2009 VS 2019 VS 2025
INDIA
Table 112: Indian Bioengineered Protein Drugs Market Estimates
and Forecasts in US$ Million by Type: 2018 to 2025
Table 113: Indian Bioengineered Protein Drugs Historic Market
Review by Type in US$ Million: 2009-2017
Table 114: Bioengineered Protein Drugs Market in India:
Percentage Share Breakdown of Sales by Type for 2009, 2019, and
2025
Table 115: Indian Bioengineered Protein Drugs Market
Quantitative Demand Analysis in US$ Million by End-Use: 2018 to
2025
Table 116: Bioengineered Protein Drugs Market in India:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 117: Indian Bioengineered Protein Drugs Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
SOUTH KOREA
Table 118: Bioengineered Protein Drugs Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by Type
for the Period 2018-2025
Table 119: South Korean Bioengineered Protein Drugs Historic
Market Analysis in US$ Million by Type: 2009-2017
Table 120: Bioengineered Protein Drugs Market Share
Distribution in South Korea by Type: 2009 VS 2019 VS 2025
Table 121: Bioengineered Protein Drugs Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
End-Use for the Period 2018-2025
Table 122: South Korean Bioengineered Protein Drugs Historic
Market Analysis in US$ Million by End-Use: 2009-2017
Table 123: Bioengineered Protein Drugs Market Share
Distribution in South Korea by End-Use: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 124: Rest of Asia-Pacific Market for Bioengineered
Protein Drugs: Annual Sales Estimates and Projections in US$
Million by Type for the Period 2018-2025
Table 125: Bioengineered Protein Drugs Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Type
for the Period 2009-2017
Table 126: Rest of Asia-Pacific Bioengineered Protein Drugs
Market Share Analysis by Type: 2009 VS 2019 VS 2025
Table 127: Rest of Asia-Pacific Demand Estimates and Forecasts
for Bioengineered Protein Drugs in US$ Million by End-Use: 2018
to 2025
Table 128: Rest of Asia-Pacific Bioengineered Protein Drugs
Market in US$ Million by End-Use: 2009-2017
Table 129: Bioengineered Protein Drugs Market Share Shift in
Rest of Asia-Pacific by End-Use: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 130: Latin American Bioengineered Protein Drugs Market
Trends by Region/Country in US$ Million: 2018-2025
Table 131: Bioengineered Protein Drugs Market in Latin America
in US$ Million by Region/Country: A Historic Perspective for
the Period 2009-2017
Table 132: Latin American Bioengineered Protein Drugs Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 133: Latin American Bioengineered Protein Drugs Market
Growth Prospects in US$ Million by Type for the Period
2018-2025
Table 134: Bioengineered Protein Drugs Historic Market Analysis
in Latin America in US$ Million by Type: 2009-2017
Table 135: Latin American Bioengineered Protein Drugs Market
by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 136: Latin American Demand for Bioengineered Protein
Drugs in US$ Million by End-Use: 2018 to 2025
Table 137: Bioengineered Protein Drugs Market Review in Latin
America in US$ Million by End-Use: 2009-2017
Table 138: Latin American Bioengineered Protein Drugs Market
Share Breakdown by End-Use: 2009 VS 2019 VS 2025
ARGENTINA
Table 139: Argentinean Bioengineered Protein Drugs Market
Estimates and Forecasts in US$ Million by Type: 2018-2025
Table 140: Bioengineered Protein Drugs Market in Argentina in
US$ Million by Type: A Historic Review for the Period 2009-2017
Table 141: Argentinean Bioengineered Protein Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 142: Argentinean Bioengineered Protein Drugs Addressable
Market Opportunity in US$ Million by End-Use: 2018-2025
Table 143: Bioengineered Protein Drugs Market in Argentina:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 144: Argentinean Bioengineered Protein Drugs Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
BRAZIL
Table 145: Bioengineered Protein Drugs Market in Brazil by
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 146: Brazilian Bioengineered Protein Drugs Historic
Market Scenario in US$ Million by Type: 2009-2017
Table 147: Brazilian Bioengineered Protein Drugs Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 148: Bioengineered Protein Drugs Quantitative Demand
Analysis in Brazil in US$ Million by End-Use: 2018-2025
Table 149: Brazilian Bioengineered Protein Drugs Historic
Market Review in US$ Million by End-Use: 2009-2017
Table 150: Brazilian Bioengineered Protein Drugs Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
MEXICO
Table 151: Bioengineered Protein Drugs Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 152: Mexican Bioengineered Protein Drugs Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 153: Mexican Bioengineered Protein Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 154: Bioengineered Protein Drugs Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2018-2025
Table 155: Mexican Bioengineered Protein Drugs Market in
Retrospect in US$ Million by End-Use: 2009-2017
Table 156: Bioengineered Protein Drugs Market Share
Distribution in Mexico by End-Use: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 157: Rest of Latin America Bioengineered Protein Drugs
Market Estimates and Projections in US$ Million by Type: 2018
to 2025
Table 158: Bioengineered Protein Drugs Market in Rest of Latin
America by Type: A Historic Review in US$ Million for 2009-2017
Table 159: Rest of Latin America Bioengineered Protein Drugs
Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 160: Rest of Latin America Bioengineered Protein Drugs
Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
Table 161: Bioengineered Protein Drugs Historic Demand Patterns
in Rest of Latin America by End-Use in US$ Million for
2009-2017
Table 162: Bioengineered Protein Drugs Market Share Breakdown
in Rest of Latin America by End-Use: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 163: The Middle East Bioengineered Protein Drugs Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 164: Bioengineered Protein Drugs Market in the Middle
East by Region/Country in US$ Million: 2009-2017
Table 165: The Middle East Bioengineered Protein Drugs Market
Share Breakdown by Region/Country: 2009, 2019, and 2025
Table 166: The Middle East Bioengineered Protein Drugs Market
Estimates and Forecasts in US$ Million by Type: 2018 to 2025
Table 167: The Middle East Bioengineered Protein Drugs Historic
Market by Type in US$ Million: 2009-2017
Table 168: Bioengineered Protein Drugs Market in the Middle
East: Percentage Share Breakdown of Sales by Type for 2009,
2019, and 2025
Table 169: The Middle East Bioengineered Protein Drugs Market
Quantitative Demand Analysis in US$ Million by End-Use: 2018 to
2025
Table 170: Bioengineered Protein Drugs Market in the Middle
East: Summarization of Historic Demand Patterns in US$ Million
by End-Use for 2009-2017
Table 171: The Middle East Bioengineered Protein Drugs Market
Share Analysis by End-Use: 2009 VS 2019 VS 2025
IRAN
Table 172: Iranian Market for Bioengineered Protein Drugs:
Annual Sales Estimates and Projections in US$ Million by Type
for the Period 2018-2025
Table 173: Bioengineered Protein Drugs Market in Iran: Historic
Sales Analysis in US$ Million by Type for the Period 2009-2017
Table 174: Iranian Bioengineered Protein Drugs Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 175: Iranian Demand Estimates and Forecasts for
Bioengineered Protein Drugs in US$ Million by End-Use: 2018 to
2025
Table 176: Iranian Bioengineered Protein Drugs Market in US$
Million by End-Use: 2009-2017
Table 177: Bioengineered Protein Drugs Market Share Shift in
Iran by End-Use: 2009 VS 2019 VS 2025
ISRAEL
Table 178: Israeli Bioengineered Protein Drugs Market Estimates
and Forecasts in US$ Million by Type: 2018-2025
Table 179: Bioengineered Protein Drugs Market in Israel in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 180: Israeli Bioengineered Protein Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 181: Israeli Bioengineered Protein Drugs Addressable
Market Opportunity in US$ Million by End-Use: 2018-2025
Table 182: Bioengineered Protein Drugs Market in Israel:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 183: Israeli Bioengineered Protein Drugs Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 184: Saudi Arabian Bioengineered Protein Drugs Market
Growth Prospects in US$ Million by Type for the Period
2018-2025
Table 185: Bioengineered Protein Drugs Historic Market Analysis
in Saudi Arabia in US$ Million by Type: 2009-2017
Table 186: Saudi Arabian Bioengineered Protein Drugs Market by
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 187: Saudi Arabian Demand for Bioengineered Protein Drugs
in US$ Million by End-Use: 2018 to 2025
Table 188: Bioengineered Protein Drugs Market Review in Saudi
Arabia in US$ Million by End-Use: 2009-2017
Table 189: Saudi Arabian Bioengineered Protein Drugs Market
Share Breakdown by End-Use: 2009 VS 2019 VS 2025
UNITED ARAB EMIRATES
Table 190: Bioengineered Protein Drugs Market in the United
Arab Emirates: Recent Past, Current and Future Analysis in US$
Million by Type for the Period 2018-2025
Table 191: United Arab Emirates Bioengineered Protein Drugs
Historic Market Analysis in US$ Million by Type: 2009-2017
Table 192: Bioengineered Protein Drugs Market Share
Distribution in United Arab Emirates by Type: 2009 VS 2019 VS
2025
Table 193: Bioengineered Protein Drugs Market in the United
Arab Emirates: Recent Past, Current and Future Analysis in US$
Million by End-Use for the Period 2018-2025
Table 194: United Arab Emirates Bioengineered Protein Drugs
Historic Market Analysis in US$ Million by End-Use: 2009-2017
Table 195: Bioengineered Protein Drugs Market Share
Distribution in United Arab Emirates by End-Use: 2009 VS 2019
VS 2025
REST OF MIDDLE EAST
Table 196: Bioengineered Protein Drugs Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Type for the Period 2018-2025
Table 197: Rest of Middle East Bioengineered Protein Drugs
Historic Market Analysis in US$ Million by Type: 2009-2017
Table 198: Rest of Middle East Bioengineered Protein Drugs
Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 199: Bioengineered Protein Drugs Market in Rest of Middle
East: Annual Sales Estimates and Forecasts in US$ Million by
End-Use for the Period 2018-2025
Table 200: Rest of Middle East Bioengineered Protein Drugs
Market in Retrospect in US$ Million by End-Use: 2009-2017
Table 201: Bioengineered Protein Drugs Market Share
Distribution in Rest of Middle East by End-Use: 2009 VS 2019 VS
2025
AFRICA
Table 202: African Bioengineered Protein Drugs Market Estimates
and Projections in US$ Million by Type: 2018 to 2025
Table 203: Bioengineered Protein Drugs Market in Africa by
Type: A Historic Review in US$ Million for 2009-2017
Table 204: African Bioengineered Protein Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 205: African Bioengineered Protein Drugs Latent Demand
Forecasts in US$ Million by End-Use: 2018 to 2025
Table 206: Bioengineered Protein Drugs Historic Demand Patterns
in Africa by End-Use in US$ Million for 2009-2017
Table 207: Bioengineered Protein Drugs Market Share Breakdown
in Africa by End-Use: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBOTT INDIA
AMGEN
BAYER AG
BIOCON
DR. REDDY’S LABORATORIES
ELI LILLY AND COMPANY
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
MERCK & CO., INC.
NOVARTIS INTERNATIONAL AG
PANACEA BIOTEC
PROBIOGEN AG

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818034/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.